Economy

Cancer center is Marcos gov’t’s first PPP project 

RAMILTIBAYAN/CC BY-SA 4.0/WIKIMEDIA COMMONS

The National Economic and Development Authority (NEDA) board has approved a plan to build a P6-billion Cancer Center in the Philippine capital — the first public-private partnership (PPP) under the Marcos government, according to the presidential palace. 

“It will be solicited from the public through the submission of a bid and will be structured as a 30-year Build-Operate-Transfer (BOT) arrangement under the BOT Law,” the Presidential Communications Office said in a statement. 

The BOT Law gives a concession to a private partner to finance, build and operate a project over a fixed term. The project will then be turned over to the state once the contract ends. 

The 300-bed capacity hospital for cancer patients inside University of the Philippines-Philippine General Hospital ground in Manila will offer “comprehensive, high-quality and affordable oncology services,” the palace said. 

The center will be built on a 3,000-square meter lot. 

“The UP-PGH’s private partner will design, engineer, construct and commission the entire new hospital building,” the palace said. 

The palace said the private entity will also maintain all nonclinical services for the hospital building, operate commercial activities, provide clinical services to private-paying patients and assume all associated costs of clinical manpower, drugs and consumables. 

UP-PGH will provide the site at no cost, transfer the existing equipment to the Cancer Institute and provide clinical services to nonpaying charity patients, it added. — Kyle Aristophere T. Atienza 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Your daily news source covering investing ideas, market stocks, business, retirement tips from Wall St. to Silicon Valley.

Disclaimer:

TheProficientInvestor.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 TheProficientInvestor. All Rights Reserved.

To Top